The new facility, Amgen India, is slated to become operational in the fourth quarter of this year and will have capacity to accommodate up to 3,000 employees. Amgen said the new tech and ...

Amgen will set up a new office and Cognizant announced plans to develop a new facility. "Marriott International selects ...

Much like the straightened origins of Apple or Microsoft, Amgen combined a relaxed attitude with determination and flexibility in dealing with limited resources. The CEO’s office was housed in a ...

Last year, Amgen agreed to buy Horizon to strengthen its rare diseases drugs portfolio and said it hopes to complete the deal in the first half of 2023. Amgen said on Monday it wasn't aware of any ...

Yesterday, Amgen announced that it would launch the ... they are doing this because studies by the Congressional Budget Office show that nixing rebates would lead to higher Part D premiums for ...

Amgen is posting strong growth across its diversified-medicines portfolio. A new weight-loss drug candidate could be a game-changer for the company. Trading at 17 times earnings, the stock offers ...

By the third day, the action movie had grossed in India and $18 million worldwide. By the end of its fourth day at the box office, Vettaiyan grossed $14.6 million in India. In North America alone ...

Amgen consistently argued to the US Patent Office that Epogen differed from natural EPO isolated from human urine. It follows that if GA-EPO has the same carbohydrate structure as natural urinary ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Amgen (AMGN) reports results for the quarter ended September 2024. While this widely-known consensus outlook is ...

Salveen Richter has given his Buy rating due to a combination of factors that highlight Amgen’s potential growth prospects. A critical focus is on the upcoming Phase 2 obesity data for MariTide ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...